Hale David F

SEC CIK: 0001024004

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

DRMA Dermata Therapeutics, Inc.Directoras of Jan 6, 2026
ONCT Oncternal Therapeutics, Inc.Directoras of Jun 24, 2024
BIOC Biocept IncDirectoras of Dec 10, 2021

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Hale David F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

ONCT Oncternal Therapeutics, Inc.

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Feb 27, 2024 (view filing)	Feb 23	4 days	Hale David FDirector	PPurchase	+714	$9.04	+$6.45K	New position714 after
Feb 27, 2024 (view filing)	Feb 23	4 days	Hale David FDirector	PPurchase	+266	$9.04	+$2.40K	+0.9%29.7K after
Jul 2, 2021 (view filing)	Jun 30	2 days	Hale David FDirector	SSale	−3.67K	$4.75	−$17.4K	−0.5%713.2K after

BIOC Biocept Inc

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Dec 10, 2021 (view filing)	Dec 9	1 day	Hale David FDirector	SSale	−374	$4.06	−$1.52K	−78.7%101 after	2 lots
Dec 10, 2021 (view filing)	Dec 9	1 day	Hale David FDirector	SSale	−71	$4.07	−$288.97	−8.2%796 after

DRMA Dermata Therapeutics, Inc.